Evidence map›Paper›PMID 27311106›Full record

ArticleJAMA otolaryngology-- head & neck surgery2016

Association of TMTC2 With Human Nonsyndromic Sensorineural Hearing Loss.

Christina L Runge, Amit Indap, Yifan Zhou, Jack W Kent, Ericka King, Christy B Erbe, Regina Cole, Jack Littrell, Kate Merath, Roland James and 8 more

Open access · bronzeAbstract read
In one paragraph

Article in JAMA otolaryngology-- head & neck surgery, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.8field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Prognostic value ofHeliyon · 2024
    Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Discovery of an O-mannosylation pathway selectively serving cadherins and protocadherins.Proceedings of the National Academy of Sciences of the United States of America · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 6 institutions in 2 countries.

Christina L RungeDepartment of Otolaryngology and Communication Sciences, Medical College of Wisconsin, Milwaukee.
Amit IndapDepartment of Biology, Boston College, Chestnut Hill, Massachusetts.
Yifan ZhouDepartment of Pharmacology and Toxicology, Medical College of Wisconsin, Milwaukee.
Jack W KentDepartment of Genetics, Texas Biomedical Research Institute, San Antonio.
Ericka KingDepartment of Otolaryngology and Communication Sciences, Medical College of Wisconsin, Milwaukee.
Christy B ErbeDepartment of Otolaryngology and Communication Sciences, Medical College of Wisconsin, Milwaukee.
Regina ColeBiotechnology and Bioengineering Center, Medical College of Wisconsin, Milwaukee.
Jack LittrellBiotechnology and Bioengineering Center, Medical College of Wisconsin, Milwaukee.
Kate MerathBiotechnology and Bioengineering Center, Medical College of Wisconsin, Milwaukee.
Roland JamesBiotechnology and Bioengineering Center, Medical College of Wisconsin, Milwaukee.
Franz RüschendorfMax Delbrück Center for Molecular Medicine, Berlin-Buch, Germany.
Joseph E KerschnerDepartment of Otolaryngology and Communication Sciences, Medical College of Wisconsin, Milwaukee.
Gabor MarthDepartment of Human Genetics, University of Utah School of Medicine, Salt Lake City.
Norbert HübnerMax Delbrück Center for Molecular Medicine, Berlin-Buch, Germany.
Harald H H GöringDepartment of Genetics, Texas Biomedical Research Institute, San Antonio.
David R FriedlandDepartment of Otolaryngology and Communication Sciences, Medical College of Wisconsin, Milwaukee.
Wai-Meng KwokDepartment of Pharmacology and Toxicology, Medical College of Wisconsin, Milwaukee8Department of Anesthesiology, Medical College of Wisconsin, Milwaukee.
Michael OlivierDepartment of Genetics, Texas Biomedical Research Institute, San Antonio5Biotechnology and Bioengineering Center, Medical College of Wisconsin, Milwaukee.
Medical College of Wisconsin · USMax Delbrück Center · DETexas Biomedical Research Institute · USBiomedical Research Institute · USBoston College · USUniversity of Utah · US

Funding

Genotype-Phenotype Relationships in Auditory NeuropathyK23DC008837 · NIDCD · MEDICAL COLLEGE OF WISCONSIN · PI RUNGE, CHRISTINA L · 2007 to 2011
$893k
NIDCD NIH HHS K23 DC008837
6 · The paper itself

Abstract

importanceSensorineural hearing loss (SNHL) is commonly caused by conditions that affect cochlear structures or the auditory nerve, and the genes identified as causing SNHL to date only explain a fraction of the overall genetic risk for this debilitating disorder. It is likely that other genes and mutations also cause SNHL.

objectiveTo identify a candidate gene that causes bilateral, symmetric, progressive SNHL in a large multigeneration family of Northern European descent. DESIGN, SETTING, AND

participantsIn this prospective genotype and phenotype study performed from January 1, 2006, through April 1, 2016, a 6-generation family of Northern European descent with 19 individuals having reported early-onset hearing loss suggestive of an autosomal dominant inheritance were studied at a tertiary academic medical center. In addition, 179 unrelated adult individuals with SNHL and 186 adult individuals reporting nondeafness were examined. MAIN OUTCOMES AND MEASURES: Sensorineural hearing loss.

resultsNine family members (5 women [55.6%]) provided clinical audiometric and medical records that documented hearing loss. The hearing loss is characterized as bilateral, symmetric, progressive SNHL that reached severe to profound loss in childhood. Audiometric configurations demonstrated a characteristic dip at 1000 to 2000 Hz. All affected family members wear hearing aids or have undergone cochlear implantation. Exome sequencing and linkage and association analyses identified a fully penetrant sequence variant (rs35725509) on chromosome 12q21 (logarithm of odds, 3.3) in the TMTC2 gene region that segregates with SNHL in this family. This gene explains the SNHL occurrence in this family. The variant is also associated with SNHL in a cohort of 363 unrelated individuals (179 patients with confirmed SNHL and 184 controls, P = 7 × 10-4). CONCLUSIONS AND RELEVANCE: A previously uncharacterized gene, TMTC2, has been identified as a candidate for causing progressive SNHL in humans. This finding identifies a novel locus that causes autosomal dominant SNHL and therefore a more detailed understanding of the genetic basis of SNHL. Because TMTC2 has not been previously reported to regulate auditory function, the discovery reveals a potentially new, uncharacterized mechanism of hearing loss.

Indexed as

Disease ProgressionMutationAdolescentAdultAgedAged, 80 and overCarrier ProteinsChromosomes, Human, Pair 12FemaleGenes, DominantGenetic Predisposition to DiseaseGenetic VariationHearing Loss, BilateralHearing Loss, SensorineuralHumansMaleCarrier ProteinsMembrane ProteinsTMTC2 protein, human

Identifiers

PMID27311106
PMCPMC5025373
OpenAlexW2429576278

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.